Research

Various efforts to attract non-white participants to the study have not succeeded, putting the study in jeopardy.

The study’s principal investigator recently provided more information about the new trial compared to a previous one in 2017.

In this new interview series, we sit down with several speakers from 2023 Cannabis Science Conference events to learn about their expertise and backgrounds in the cannabis industry. Join us to learn more about Dr. Peter Grinspoon, Jini Glaros, Dr. Miyabe Shields, and Adam Jacques.

A recent study in Molecular Psychiatry suggests CBD use during pregnancy may harm fetal brain development, posing a cognitive risk.

Let’s meet Riley Kirk, PhD, cannabis and natural product chemist, cannabis educator, and cannabis research scientist.

A recent study sought to examine the occurrence of cannabis use disorder in patients and recreational users, specifically in a state with legal cannabis access.

Let’s meet Miyabe Shields, PhD, a queer and neurodivergent stoner scientist and avid psychonaut with more than 13 years of experience in academic and industrial research.

This column reviews a study published by cannabis industry design and construction professionals and describes the impact of energy regulations affecting heating, ventilation, and air conditioning (HVAC) system selection in cannabis production facilities.

This article delves into the aspects of horticultural light intensity and spectra as well as their relative influence on cannabis photosynthesis, photomorphogenesis, and overall yield.

See the program overview for the upcoming Cannabis Science Conference Fall in Providence, Rhode Island September 20-22nd.

A recently published study tracked American adults’ opinions over several years on smoking cannabis compared to smoking tobacco.

The small study will begin later this year and seeks to further understand brain function in gambling disorder.

Our sister publication, dvm360, recently published breakthrough research from a study involving CBD+CBDA oil as a potential treatment for atopic dermatitis in dogs.

Pharmaceutical developer Oxford Cannabinoid Technologies recently described the potential of its latest cannabinoid-based immunotherapy treatment.

A recently published study compared various methods and associated costs of treating difficult-to-treat depression.

This blog installment takes a look at autism spectrum disorder (ASD) and how the endocannabinoid system (ECS) plays a key role. Topics covered include the characterization of ASD, ECS dysfunction in ASD patients and comorbidities, and how cannabis addresses ASD symptoms.

A reportedly first-of-its-kind study tested the idea that cannabis use leads to other substance use in young adults.

The FDA issued first draft guidance on clinical trials with psychedelic drugs.

Researchers at Weill Cornell Medicine aim to understand the interaction between cannabis use and the virus.

Noting the current lack of an accurate cannabis breathalyzer, researchers in a protocol development study analyzed levels of THC before and after participants smoked cannabis.

Cal Poly Humboldt plans a two-year community-based study on the plant genetics and history from legacy cannabis communities in the state.

This article provides insights into the opportunities involving the genetic modification of cannabis.

Searching for purer, minor cannabinoids is the goal of new extraction research as extractors dig deeper into the diversity of the plant.

The current challenges and future perspectives of the purification of cannabinoids from cannabis extracts are presented in this review article.

One important element of creating the ideal growing environment for cannabis is often overlooked: air quality. Here, we look at why this is important as well as best practices for mitigating poor air quality.

Newly passed legislation in Arizona establishes funding for research into therapeutic potential of psilocybin.

The effects of worms consuming cannabis were researched in a experiment showing that that they got the munchies and craved junk food.

Don't miss this Noid Factoid from Nathan Johnson, PhD, the Co-Founder and CEO of VERNE Bioanalytics.

While placebo-controlled randomized trials are lacking, a few early studies show promise for cannabis and arthritis, and surveys show that many arthritis patients are already finding relief using cannabis to treat their symptoms.